Onux gets US nod for "needlescopic" therapy:
This article was originally published in Clinica
Executive Summary
Onux Medical has received US FDA 510(k) market clearance for a coil fixation device that can allow doctors to "suture" percutaneously through a small gauge needle. The En Garde device, which can be used in endoscopic and open surgical procedures, lends itself to applications in difficult-to-access regions or when traditional open surgical access is contraindicated, says the Hampton, New Hampshire firm.
You may also be interested in...
Synthekine Joins Quest To Tame IL-2 In Cancer Therapies
First clinical data from Synthekine’s IL-2 candidate and that of rivals Medicenna were presented at the AACR, suggesting there’s life in the modality yet.
Swisse Supplements Take Bigger Slice Of Chinese Market
Australian-heritage Swisse grew its share of China's supplements market in 2023 by delivering tailored products to an increasingly health conscious population.
Novartis Draws Out Its APPLAUSE
Another data drop from Fabhalta’s IgAN trial looks encouraging, despite a missing abstract.